USE OF ARTIFICIAL INTELLIGENCE IN A PULMONARY FIBROSIS CLINIC
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Survey.
- Who it may be relevant to
- Registry conditions: Interstitial Disease. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
USE OF ARTIFICIAL INTELLIGENCE IN THE BACK-OFFICE OF A SPECIALIZED MEDICAL CLINIC FOR PULMONARY FIBROSIS (LLM-ILD)
Overview
The present study aims to evaluate the usefulness of artificial intelligence (AI) in the back-office of an ILD (Interstitial Lung Disease) clinic.
Interventions
- Other Survey
The patients will receive questionnaires. The enrolled patients will be asked to provide feedback on the answers they read.
Primary outcome measures
- Variation of VAS scores of clarity of the message in questionnaires administered at T1 and at T2 [Time frame: 15 days]
- Variation of VAS scores of empathy conveyed in questionnaires administered at T1 and at T2 [Time frame: 15 days]
Secondary outcome measures (2)
- Percentage of answers recognised correctly as answers provided by AI among the total of answers flagged as provided by AI by study subjects [Time frame: 1 day]
- Stratify the results by patients' demographic characteristics and past experiences with artificial intelligence systems. [Time frame: 1 day]
Eligibility criteria
Inclusion criteria
\- Patients attending ILD clinic of the IRCCS Fondazione Policlinico A. Gemelli.
Exclusion criteria
- Patients unable or unwilling to sign the informed consent
- Patients who are senders of one of the emails chosen for the questionnaire
- Patients with manifest inability to fill out the questionnaire
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Other
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT06852794 · 7002